Fcγ receptor polymorphisms in systemic lupus erythematosus: Association with disease and in vivo clearance of immune complexes

Arthritis and Rheumatism

Volumn 43, Issue 12, 2000, Pages 2793-2800

  Dijstelbloem, Hilde M ^a   Bijl, Marc ^a   Fijnheer, Rob ^b   Scheepers, Ronald H M ^b   Oost, Wia W ^a   Jansen, Marc D ^b   Sluiter, Wim J ^a   Limburg, Pieter C ^a   Derksen, Ronald H W M ^b   Van De Winkel, Jan G J ^b   Kallenberg, Cees G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT;

ADULT; AGED; ALLOTYPE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHROCYTE; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; IN VIVO STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; BLOOD; CHILD; GENETICS; GENOTYPE; HALF LIFE TIME; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTIGEN-ANTIBODY COMPLEX; CHILD; FEMALE; GENOTYPE; HALF-LIFE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 0034353414     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200012)43:12<2793::AID-ANR20>3.0.CO;2-6     Document Type: Article

References (40)

1. The role of Fcγ receptors in mononuclear phagocyte system function
2. Fc receptors
3. Clinical relevance of Fcγ receptor polymorphisms
4. IgG receptor polymorphisms: Risk factors for disease
5. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets
6. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease
7. FcγRIIIa-158V/F polymorphism influences the binding of IgG by NK cell FcγRIIIa, independently of the FcγRIIIa-48L/ R/H phenotype
8. Allelic polymorphisms of human Fc gamma receptor IIa and Fc gamma receptor IIIb: Independent mechanisms for differences in human phagocyte function
9. Role of the neutrophil FcγRIIa (CD32) and the FcγRIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes
10. Increased proportion of responders to a murine anti-CD3 monoclonal antibody of the IgG1 class in patients with systemic lupus erythematosus (SLE)
11. Skewed distribution of IgGFc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients
12. FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans
13. Abnormal distribution of Fcγ receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus
14. FcγRIIa polymorphism in systemic lupus erythematosus (SLE): No association with disease
15. FcγRIIa polymorphism in systemic lupus erythematosus
16. The FcγRIIIA-158F allele is a risk factor for systemic lupus erythematosus
17. Fcγ receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: Association with clinical symptoms
18. Altered distribution of Fcγ receptor IIIA alleles in a cohort of Korean patients with lupus nephritis
19. Human Fc gamma receptor IIA (FcγRIIA) genotyping and association with systemic lupus erythematosus (SLE) in Chinese and Malays in Malaysia
20. Frequency of the FcγRIIIA-158F allele in African American patients with systemic lupus erythematosus
21. Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele specific oligonucleotide probes
22. Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity?
23. The 1982 revised criteria for the classification of systemic lupus erythematosus
24. Lupus nephritis
25. Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: A study of 21 individuals from 14 families
26. Renal involvement in systemic lupus erythematosus: A study of 180 patients from a single center
27. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study
28. Patients with systemic lupus erythematosus and Jaccoud's arthropathy: A clinical subset with an increased C reactive protein response?
29. Nucleosomes and the pathogenesis of lupus nephritis
30. The major receptor for C-reactive protein on leukocytes is Fcγ receptor II
31. C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific
32. Fcγ receptor polymorphisms in Wegener's granulomatosis: Risk factors for disease relapse
33. Deletion of Fcγ receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis
34. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis
35. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value
36. Mortality studies in systemic lupus erythematosus: Results from a single center. II. Predictor variables for mortality
37. Cytotoxic antibodies trigger inflammation through Fc receptors
38. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees
39. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus
40. Variant genotypes of the low-affinity Fcγ receptors in two control populations and a review of low-affinity Fcγ receptor polymorphisms in control and disease populations